Picture of G2GBio logo

456160 G2GBio Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Momentum

Relative Strength (%)
1mn/a
3mn/a
6mn/a
1yrn/a
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w High-24.7%
50d MA-4.21%
200d MA-4.21%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value46.28
Price to Tang. Book47.65
Price to Free Cashflown/a
Price to Sales1,996.65
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-75.76%
Return on Equity-164.2%
Operating Margin-4091.97%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of G2GBio EPS forecast chart

Profile Summary

G2GBio Inc is a Korea-based company principally engaged in the development of long-acting pharmaceutical formulations. The Company is mainly engaged in the development of long-acting pharmaceutical products, including pipeline candidates such as GB-7001 (for diabetes and obesity) and GB-5001 (for dementia).

Directors

    Last Annual
    December 31st, 2024
    Last Interim
    March 31st, 2025
    Incorporated
    March 22nd, 2017
    Public Since
    August 14th, 2025
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    kr flag iconKorea Exchange - KOSDAQ
    Shares in Issue
    5,365,694
    Blurred out image of a map
    Address
    21, CHEONGJU, 28161
    Web
    https://www.g2gbio.com/
    Phone
    +82 432706000
    Auditors
    Shinwoo Accounting Corp.

    456160 Share Price Performance

    Similar to 456160

    Picture of 3Billion logo

    3Billion

    kr flag iconKorea Exchange - KOSDAQ

    Picture of ABion logo

    ABion

    kr flag iconKorea Exchange - KOSDAQ

    Picture of ABL Bio logo

    ABL Bio

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Amicogen logo

    Amicogen

    kr flag iconKorea Exchange - KOSDAQ

    Picture of AprilBio Co logo

    AprilBio Co

    kr flag iconKorea Exchange - KOSDAQ

    FAQ